The HMGIC gene has been implicated in the control of cell proliferation and development. We show here that HMGIC has multiple mRNA isoforms that arise by transcription initiation from alternative tandem promoters. These transcripts are not only dierentially expressed between cell lines, but they can also dier within an individual cell line, in response to particular stimuli. Whereas quiescent 3T3-L1 preadipocytes express low levels of HMGIC mRNA, stimulation by serum results in a dramatic upregulation with the characteristics of a delayed-early response gene. Characterization of involved signal transduction pathways showed that both FGF-1 and PDGF-BB are strong inducers of HMGIC expression mediated via both the PI-3 kinase and MAP kinase pathways. In order to characterize the regulatory elements, sequences upstream of the translation initiation site of HMGIC were assayed for promoter activity. The HMGIC 5'¯anking sequences had constitutive promoter activity in all cell lines tested, suggesting that HMGIC is regulated by negative regulatory elements that were not present in the 5'-anking regions analysed here.
Introduction
Recurrent chromosomal rearrangements involving human chromosome segment 12q13-15 are often observed in a variety of commonly occurring solid tumors including, uterine leiomyomas, lipomas, pleomorphic adenomas of the salivary glands, pulmonary chondroid hamartomas (PCHs), endometrial polyps and angiomyxomas (for review see Jansen et al., 1999 , and references therein). Due to the high incidence of these tumors, translocations involving this particular region of chromosome 12q13-15 are probably the most common chromosomal rearrangement in humans. The 12q13-15 breakpoint region has been cloned (Schoenmakers et al., 1995) and the HMGIC (high mobility group protein IC) gene has been identi®ed as the gene involved in these rearrangements (Ashar et al., 1995; Schoenmakers et al., 1995) .
The HMGI family of high mobility group chromosomal proteins consists of three members: HMGI and HMGY, which are produced by alternative splicing from a single gene on chromosome 6p21 (Johnson et al., 1989) and HMGIC which is the product of a separate gene on chromosome 12q15 (Man®oletti et al., 1991) . HMGI proteins belong to a group of low molecular mass non-histone chromosomal proteins that are soluble in 5% perchloric acid. HMGI proteins consist of about 100 amino acids, have a variable Nterminus, an acidic tail and three short DNA binding domains (for a review see Bustin and Reeves, 1996) . The DNA binding domains have been termed AThooks and they bind to AT-rich stretches of DNA with nanomolar anity (Reeves and Nissen, 1990) . The structure of an HMGI(Y)-DNA complex has been determined, structurally de®ning the AT-hook minor groove binding motif of the HMGI family (Huth et al., 1997) . In addition, HMGI(Y) has been shown to be involved in leiomyomas, endometrial polyps, and PCHs (Kazmierczak et al., 1998) suggesting a similar but less general involvement as HMGIC in tumor development.
Although their structure is reminiscent of that of classical transcription factors and they do have a function in regulation of gene expression, HMGI proteins do not have transcription activation activity by themselves. Their exact function is not fully understood but their role in growth and gene regulation will likely be the result of a combination of eects. Several observations suggest that HMGI proteins play a critical role at promoter regions in the correct assembly and stabilization of higher order protein-DNA complexes (also called enhanceosome) required for ecient transcriptional activation of genes (Carey, 1998) .
Their principal architectural role seems to be in the modulation of DNA conformation like kinking or bending DNA. On the other hand, HMGI(Y) has been shown to reverse or prevent intrinsic distortions in DNA conformation as established at the interferon-b enhancer (Falvo et al., 1995) . Whatever the exact change in DNA conformation, by binding to the minor groove, HMGI proteins seem to facilitate speci®c recognition of the opposing major groove by other transcription factors. In addition, HMGI(Y) has also been shown to interact directly, through proteinprotein interaction sites, with transcription factors including NFK-b and ATF2 (Du et al., 1993) , Tst1/ Oct6 (Leger et al., 1995) and NF-Y 9 (Currie, 1997) .
Besides their role in benign tumor formation, HMGI(Y) and HMGIC overexpression has been shown to be directly correlated with the degree of metastatic aggressiveness of malignant tumors but not with growth rate (Berlingieri et al., 1995; Chiappetta et al., 1998 and references therein) .
As already indicated above, it is generally assumed that HMG proteins belong to a group of abundant, low molecular mass non-histone chromosomal proteins. Although this might be true for the HMG1/2 and HMG14/17 families, it has to be stressed that in contrast to other HMG proteins, the expression of HMGI(Y) and HMGIC varies dramatically and seems to be regulated at multiple levels including developmental stage, cell type, transformation state, hormonal and cell cycle conditions. Here, we report about studies on the regulation of HMGIC gene expression.
Results

Characterization of HMGIC mRNA isoforms
A large number of cell lines were screened by Northern blotting for possible HMGIC mRNA expression. Table  1 summarizes the cell lines screened. It is apparent that some cell lines express high levels of HMGIC mRNA, while others express low levels of it. Several of the cell lines tested had no detectable HMGIC mRNA. Most of the human cell lines expressed two mRNA isoforms, respectively 3.7 and 4.4 kb, but their relative amounts diered between cell lines (Figure 1 ). It is of interest to note that cell lines of embryonic origin like 3T3-L1 embryonal preadipocytes, RD rhabdomyosarcoma, and TERA-2 embryonal carcinoma expressed the highest levels of HMGIC mRNA. This is in accordance with the embryonic expression pattern of HMGIC.
Dierential expression of HMGIC mRNA isoforms
In order to investigate whether the expression of alternative HMGIC mRNA transcripts was subject to regulation, two dierentiation models were studied.
Treatment of TERA-2 cells with retinoic acid (RA) inhibits their proliferation and induces these cells to dierentiate (Andrews, 1988) . As shown in Figure 2 , TERA-2 cells expressed mainly a 3.7 kb mRNA isoform when they are in log phase. Control cells kept on growing during the course of the experiment and became supercon¯uent. Between 6 and 8 days after plating, there is a switch from the 3.7 to a 4.4 kb mRNA isoform. RA-treated cells, on the other hand, Figure 2 , there is a switch to the 4.4 mRNA isoform already within 2 days of treatment with RA. In addition, a 3.9 kb transcript also appeared. Besides the switch in mRNA isoforms, there was also a decrease in HMGIC mRNA levels and this seemed even more pronounced for HMGI(Y). Since it is known that HMGI(Y) is regulated by multiple promoters (Friedmann et al., 1993) , the transcription initiation sites for the HMGIC mRNA isoforms were also determined as described in a section below. As might be expected, alternative promoter usage appeared to be responsible for these multiple mRNA isoforms.
Regulation of HMGIC expression during adipocyte dierentiation
Another well characterized dierentiation model of embryonic origin is the mouse preadipocyte cell line 3T3-L1, which can dierentiate to adipocytes after hormonal stimulation (Smas and Sul, 1995) . Exponentially growing 3T3-L1 preadipocytes expressed high levels of the 3.7 kb HMGIC mRNA isoform ( Figure  3a ). When 3T3-L1 preadipocytes were induced to dierentiate to adipocytes by adding the differentiation cocktail described under Materials and methods the level of HMGIC mRNA decreased dramatically (Figure 3a) . A kinetic analysis showed a delayed-early response of HMGIC expression during the differentiation of preadipocytes to adipocytes. HMGIC mRNA levels peaked about 6 h after addition of the dierentiation cocktail and decreased steeply to basal non-stimulated levels within 24 h (Figure 3b ). Three hours after induction, two mRNA isoforms were expressed. A more detailed kinetic analysis (in combination with an extended electrophoresis time) showed that already after 2 h, a 5-fold induction occurred and at that time only the 3.7 kb transcript Figure 2 Northern blot analysis of TERA-2 cells cultured in the absence (lanes 1 ± 7) or presence of 1 mM retinoic acid (lanes 8 ± 14). Cells were harvested at 0 days (lanes 1 and 8), 2 days (lanes 2 and 9), 4 days (lanes 3 and 10), 6 days (lanes 4 and 11), 8 days (lanes 5 and 12), 12 days (lanes 6 and 13) and 16 days (lanes 7 and 14). Filters were hybridized with a probe speci®c for HMGIC (upper panel) and re-hybridized with a probe speci®c for HMGI(Y) (middle panel). The lower panel shows methylene blue staining of 18S rRNA as a loading control Figure 3 Northern blot analysis of 3T3-L1 cells. (a) HMGIC mRNA levels in exponentially growing 3T3-L1 preadipocytes (lane 1), 3T3-L1 adipocytes after 7 days of dierentiation (lane 2) and 3T3-L1 cells kept quiescent for 7 days without the dierentiation cocktail (lane 3). (b) HMGIC mRNA levels 0 h, 3 h, 6 h, 9 h, 14 h, 24 h (lanes 1 ± 6) after the dierentiation cocktail was added. (c) HMGIC mRNA levels 0 h, 1 h, 2 h, 3 h, 4 h, 5 h (lanes 1 ± 6) after addition of the dierentiation cocktail. The lower part in each ®gure panel shows methylene blue staining of 18S rRNA as a loading control was induced (Figure 3c) . After 3 h, there was a 40-fold increase of mRNA levels and the 3.7 and 3.9 kb transcripts were as abundant. The induction of HMGIC mRNA levels after 5 h was over 100-fold. Delayed-early response genes require protein synthesis for their activation (Lanahan et al., 1992 , and references therein). To determine whether HMGIC mRNA induction required de novo protein synthesis, cells were preincubated for 1 h with the protein synthesis inhibitor cycloheximide (1 mg/ml) and subsequently induced in the presence of cycloheximide. Pretreatment with cycloheximide completely abolished the HMGIC mRNA induction by the dierentiation cocktail, whereas addition of cycloheximide 3 or 6 h after induction did not result in a signi®cant eect on the peak induction of HMGIC. The mRNA levels, however, were more sustained (Figure 4 ). This suggests that inhibition of protein synthesis 3 ± 6 h after induction results in the downregulation of factors required for the transient character of HMGIC mRNA induction. Together, the results described above show that there is not only a dierential expression pattern of multiple HMGIC mRNA isoforms between dierent cell lines, but that the expression pattern of the HMGIC isoforms can dier, also within a particular cell line, in response to a particular stimulus or growth condition.
Characterization of transcription initiation sites of HMGIC
Both the human (Ashar et al., 1996; Chau et al., 1995; Schoenmakers et al., 1995) and the murine Zhou et al., 1996) HMGIC genes have been cloned and characterized. These studies suggest the presence of multiple transcription initiation sites but the mapped sites do not coincide. The apparent discrepancies in the reported transcription initiation sites and our ®nding that HMGIC expresses multiple mRNA isoforms prompted us to address this matter.
Our initial attempts to determine the transcription start sites of HMGIC using both primer extension and RNase protection analysis resulted in ambiguous results (not shown). This is most likely due to the high GC content in the region of transcription initiation and the presence of highly repetitive and polymorphic dinucleotide (CT) repeats (Ishwad et al., 1997) . mRNAs with GC-rich leaders and repeats may form secondary structures that can interfere with the conventional assays. In addition, HMGIC is a TATAless gene and such genes are often characterized by heterogeneous transcription start sites. The combination of heterogeneous transcription initiation and a GC-rich leader containing repeats often makes the mapping of the transcription start sites a cumbersome exercise. Therefore, in order to determine the predicted alternative start sites of HMGIC, we used RNA linkermediated RACE (RLM ± RACE), a new PCR-based method designed to amplify only cDNAs that are extended to the cap site. This method can circumvent the mechanisms by which truncated 5'-ends are generated (see Materials and methods section).
Using RLM ± RACE, a major cap site was mapped 201 nucleotides upstream of the ATG, in human cell lines Hep3B, 293, and TERA-2, and 228 nucleotides (due to some insertions in the mouse sequence) upstream of the ATG in mouse 3T3-L1 cells. This start site region has an extremely pyrimidine-rich sequence and the major start site was at the sequence TCTCTTTTT [74, +5] , that resembles so-called initiator sequences. There were a number of minor start sites directly upstream of this major start site but the 34 (human) or 55 (mouse) nucleotides upstream of this major start site contained exclusively CTs and it is known that RNA polymerase II starts preferentially at these pyrimidine-rich regions. This major start site was used to express the 3.7 kb mRNA isoform in mouse 3T3-L1 preadipocytes and in human cells that express both the 3.7 and the 4.4 kb HMGIC transcripts. We also used RLM ± RACE on RNA isolated from density-arrested 3T3-L1 cells that had been stimulated with serum for 3 h. This results in the expression of both a 3.7 and a 3.9 kb transcript (Figure 3c ). The 3.9 kb transcript arose from transcription initiation within a cluster located between 455 and 411 nucleotides upstream of the ATG.
We also used RLM ± RACE on mRNA isolated from retinoic acid treated TERA-2 cells. Retinoic acid treatment of TERA-2 cells results in a switch from the 3.7 kb as the major transcript to the 4.4 kb as the major transcript with the appearance of an intermediate 3.9 kb transcript (Figure 2 ). RLM ± RACE analysis showed that the 4.4 kb transcript arose from a cluster of start sites located between 893 and 790 nucleotides upstream of the ATG and the 3.9 kb transcript arose from a cluster of start sites between 477 and 364 nucleotides upstream of the ATG.
Together, our results indicate that in human TERA-2 cells, HMGIC has three major transcription initiation sites which are located about 200, 450 and 850 nucleotides upstream of the ATG, and are differentially utilized. In mouse 3T3-L1 preadipocytes, there is a major transcription initiation site 228 bp upstream of Figure 4 Eect of cycloheximide (1 mg/ml) on HMGIC mRNA induction in 3T3-L1 cells. Cycloheximide was added 1 h before the addition of the dierentiation cocktail (CHX71), 3 h (CHX+3) or 6 h after such addition (CHX+6). Cells were harvested at 0, 3, 6, 9, 14 and 24 h after the addition of dierentiation cocktail and subjected to Northern blot analysis. Methylene blue staining of 18S rRNA was performed as a loading control (not shown) the ATG and during exit from quiescence there is a transient use of an alternative transcription initiation site about 425 nucleotides upstream of the ATG.
Characterization of signal transduction pathways involved in regulation of HMGIC expression
Quiescent 3T3-L1 preadipocytes express low levels of HMGIC mRNA. Stimulation by serum results in a dramatic induction of HMGIC mRNA expression with the characteristics of a delayed-early response gene (Figure 3) . Inhibitors of distinct signaling pathways were used to dissect the pathways by which serum induces HMGIC gene expression in quiescent 3T3-L1 preadipocytes.
Mouse 3T3-L1 cells dierentiate to adipocytes in response to hormonal induction. The hormone cocktail includes fetal calf serum, dexamethasone, insulin and IBMX. To ®rst determine which of the components of the dierentiation cocktail were responsible for the induction of HMGIC mRNA during adipocyte dierentiation, quiescent density-arrested 3T3-L1 cells were treated with each component separately or in combination. At intervals after factor addition, total RNA was isolated and HMGIC mRNA levels were determined by Northern blot analysis. Quiescent cells expressed a constant low basal level of HMGIC mRNA as illustrated for a period of 24 h ( Figure 5,  NON) . Replacing the medium for fresh medium containing 10% FCS resulted in a dramatic increase in HMGIC mRNA levels (over 100-fold) that peaked between 6 and 9 h after serum addition and decreased dramatically again to almost basal levels within 24 h. The kinetics of this delayed-early response were similar to that of the complete dierentiation cocktail (see Figure 3 ). Replacing the medium for serum-free medium had no eect, indicating that the FCS was responsible for the induction and not a nutrient present in the medium (Figure 5 , SF). Dexamethasone or IBMX alone did not induce HMGIC mRNA levels (data not shown). Similarly, insulin, IGF-1, IGF-II or a combination of insulin, dexamethasone and IBMX had no eect on HMGIC mRNA levels ( Figure 5 ). These results clearly indicate that FCS contained factors that were responsible for the observed induction of HMGIC expression.
We tested several other growth factors for their eect on HMGIC expression. EGF induced HMGIC mRNA levels slightly ( Figure 5 ). FGFs were also able to induce HMGIC mRNA, FGF-1 being more potent than FGF-2 (Figure 6 ). PDGF-AA was able to slightly induce HMGIC expression. The PDGF-AB heterodimer was clearly more potent, while the PDGF-BB homodimer was the most potent PDGF isoform ( Figure 6 ). The time of appearance of HMGIC mRNA when quiescent density arrested 3T3-L1 cells were treated with FGF-1 or PDGF-BB alone was similar to that seen for FCS. However, the HMGIC mRNA levels were more sustained. HMGIC mRNA levels decreased to almost basal levels around 14 and 24 h after total serum stimulation, whereas elevated levels of HMGIC mRNA were present 24 h after the single growth factor addition. Combining FGF-1 or PDGF-BB (commitment factors) with IGF-I or insulin Figure 5 Northern blot analysis showing the eect of dierentiation cocktail components on HMGIC mRNA induction. The medium of quiescent density-arrested 3T3-L1 cells was replaced by serum free medium alone (SF) or serum free medium containing 10% fetal calf serum (FCS), 10% fetal calf serum and 0.5 mM IBMX (FCS+IBMX), 50 ng/ml EGF (EGF), 10 mg/ml insulin (INSULIN), 25 ng/ml IGF-I (IGF-I), 25 ng/ml IGF-II (IGF-II), 1 mM dexamethasone and 10 mg/ml insulin and 0.5 mM IBMX (DEX+INSULIN+IBMX). Non-treated cells were used as controls (NON). At intervals after factor addition (0, 3, 6, 9, 14 and 24 h) total RNA was isolated and subjected to Northern blot analysis. Methylene blue staining of 18S rRNA was performed as a loading control (not shown) (progression factors) did not result in the transient induction pattern seen for FCS (Figure 6 ). This suggests that the sustained HMGIC mRNA levels were not the result of the incapability of the cells to progress to late stages of the cell cycle. Remarkably, insulin signi®cantly reduced the HMGIC mRNA induction by FGF-1 but not PDGF-BB (Figure 6 ). This indicates that in these cells, insulin and FGF-1 may compete for some components of the same signal transduction pathway.
As an initial characterization of signal transduction pathways mediating the delayed-early response of HMGIC, we treated density-arrested quiescent 3T3-L1 cells with speci®c inhibitors prior to and during their stimulation with serum or puri®ed growth factors. Density-arrested cells were pretreated for 1 h with the inhibitor and were subsequently stimulated with serum in the presence of the inhibitor.
IBMX (an inhibitor of phosphodiesterase which results in elevated cAMP levels) was able to signi®cantly block the HMGIC induction by FCS ( Figure 5 ). This is in agreement with the fact that elevated cAMP levels (through cAMP-dependent protein kinase A) appears to result in the prevention of the Raf-1-ERK2 cascade activation that occurs in response to growth factors (Burgering and Bos, 1995, and references therein). Treatment of 3T3-L1 cells with tyrphostin AG1296, an inhibitor of the PDGF alpha and beta receptors (Levitzki, 1996) , resulted in a strong inhibition of the HMGIC mRNA induction by serum (Figure 7a) . Treatment of cells with tyrphostin AG1478, an inhibitor of the EGF receptor tyrosine kinase (Levitzki, 1996) , resulted in a slight inhibition of the HMGIC mRNA induction. This suggests that PDGF might be the principal growth factor mediating the serum response of HMGIC. PDGF receptors are known to signal through both MAP kinase and PI3-kinase pathways. Accordingly, treatment of cells with PD98059, an inhibitor of MEK (Dudley et al., 1995) , resulted in a strong inhibition of the HMGIC mRNA induction by serum. The PI3-kinase inhibitors wortmannin and LY294002 (Levitzki, 1996) signi®cantly inhibited the induction of HMGIC mRNA by serum, strongly indicating the involvement of this pathway in the regulation of HMGIC expression. ETYA, a lipooxigenase inhibitor known to stimulate adipocyte dierentiation (Kim and Spiegelman, 1996) significantly inhibited the HMGIC mRNA induction by serum. Okadaic acid, a potent inhibitor of protein phosphatase 1 and 2A (Park et al., 1992) , resulted initially in the inhibition of HMGIC mRNA induction by serum. However, after 24 h of treatment there was a dramatic upregulation of the HMGIC mRNA levels (Figure 7a ). Exceptionally, even without serum Figure 6 Northern blot analysis showing the eects of growth factors on HMGIC mRNA levels. The medium of quiescent densityarrested 3T3-L1 cells was replaced by serum free medium alone (SF) or serum free medium containing 25 ng/ml FGF-1 (FGF-1), 25 ng/ml FGF-2 (FGF-2), 25 ng/ml PDGF AA (PDGF AA), 25 ng/ml PDGF AB (PDGF AB), 25 ng/ml PDGF BB (PDGF BB), 25 ng/ml FGF-1 and 25 ng/ml IGF-I (FGF-1+IGF-I), 25 ng/ml FGF-1 and 10 mg/ml insulin (FGF-1+INS), 25 ng/ml PDGF BB and 25 ng/ml IGF-I (PDGF BB+IGF-I) or 25 ng/ml PDGF BB and 10 mg/ml insulin (PDGF BB+INS). At intervals after factor addition (0, 3, 6, 9, 14 and 24 h) total RNA was isolated and subjected to Northern blot analysis. Methylene blue staining of 18S rRNA was performed as a loading control (not shown) addition, the HMGIC mRNA levels were dramatically increased after 24 h of okadaic acid treatment (data not shown). A more detailed kinetic analysis showed that the HMGIC mRNA levels were induced between 9 and 14 h after okadaic acid treatment (Figure 7b ). This observation suggests that phosphorylation/dephosphorylation events are responsible for the transient character of the HMGIC response to serum and that the inhibition of phosphatases overcomes the inhibitory forces that repress HMGIC expression is quiescent cells. This is consistent with the reported tumor promoting eects of okadaic acid.
Characterization of the HMGIC promoter
In order to characterize the regulatory elements involved in the serum delayed-early response of HMGIC, sequences upstream of the translation initiation site of the human HMGIC gene were cloned in front of the luciferase gene and functionally characterized for promoter activity in transient transfection assays. A schematic representation of the 5'-anking region and the deletion mutants analysed is given in Figure 8a . The absolute level of luciferase activity was comparable to that of the SV40 early promoter and enhancer as present in the pGL2-Promoter vector and this level decreased incrementally as the promoter region was shortened. Both the promoter strength and the incremental decrease in promoter activity that is observed as the HMGIC promoter is progressively truncated, were similar in cells that express high levels of HMGIC like DLD-1 (Figure  8b and c) or Hep3B, PA-1, TERA-2, 3T3-L1, and HT1080 (data not shown). To our surprise, the same observation was made for cells that do not express HMGIC, at Northern blot detection level, like Neuro-2a (Figure 8d and e) or AtT20, COS-1, and MOLT-4 (data not shown). These results clearly suggest that the HMGIC gene is regulated by negative regulatory elements that were not present in the 5'-¯anking regions analysed here or that, alternatively, HMGIC could be regulated at the post-transcriptional level. Figure 7 Northern blot analysis showing the eects of various inhibitors on HMGIC mRNA levels. (a) Quiescent, density-arrested cells were pretreated for 1 h with inhibitor and were subsequently stimulated with serum in the absence of inhibitor (FCS) or in the presence of ETYA (50 mM), okadaic acid (50 nM), rapamycin (50 ng/ml), PD98059 (20 mM), LY294002 (20 mM), worthmannin (50 nM), AG1478 (50 nM) or AG1296 (10 mM). At intervals after serum and factor addition (0, 1.5, 3, 6, 9 and 24 h) total RNA was isolated and subjected to Northern blot analysis. Methylene blue staining of 18S rRNA was performed as a loading control (not shown). (b) Quiescent, density-arrested cells were pretreated for 1 h with okadaic acid (50 nM) and were subsequently stimulated with serum in the presence of okadaic acid. At intervals after serum addition (0, 3, 6, 9, 14, 16, 18, 20, 22, 24, 26, 29, 36 and 41 h) total RNA was isolated and subjected to Northern blot analysis. Methylene blue staining of 18S rRNA was performed as a loading control (not shown) Induction of HMGIC mRNA by serum is at least partially a transcriptional event
In order to determine whether the increase in HMGIC mRNA levels after serum induction is due to enhanced transcription, we performed an RT ± PCR assay developed to amplify a region of the heterogeneous nuclear RNA (hnRNA) transcripts encompassing the exon 1-intron 1 boundary. Measuring hnRNA levels is useful in order to determine a gene's transcriptional state (Elferink and Reiners, 1996) . Detection of HMGIC hnRNA transcripts during stimulation of quiescent 3T3-L1 cells paralleled the serum induced increase in mRNA transcripts consistent with a transcriptional response (Figure 9 ). Consistent with the expectation, the level of pre-mRNA peaked between 3 and 6 h after serum induction while the mRNA level peaked between 6 and 9 h after serum stimulation. These results indicate that the increase in HMGIC gene expression was, at least in part, a transcriptional phenomenon. In order to explore the HMGIC promoter regulation, we tested the eect of p21Ras-mediated signaling on HMGIC promoter activity by co-transfecting the 5'-Bam HMGIC promoter construct and a plasmid directing the expression of constitutive active p21Ras (Leu61; Medema et al., 1991) . We observed an 18-fold enhancement of HMGIC promoter activity ( Figure  8f ). This activation by p21Ras is in the same range as observed with a Fos promoter construct (Schonthal et al., 1988) which was included as positive control.
To investigate whether HMGIC is regulated at a post-transcriptional level, we replaced the original SV40 3'-nontranslated region of the pGL2-Basic vector (luciferase expression directed by the HMGIC 5'-BamHI promoter fragment; Figure 8a ) with the complete HMGIC 3'-nontranslated region. This resulted in about 7 ± 15-fold lower luciferase levels (data not shown). Transient transfections of this construct in cells that were non-induced or induced by serum did not result in signi®cantly diering luciferase levels when compared to the original HMGIC-promoter-luciferase construct containing the SV40 3'-nontranslated region (data not shown). These results indicate that although the 3'-nontranslated region of HMGIC results in decreased luciferase levels, most likely due to a shorter half-life of the transcripts (Geurts et al., 1997) , the stability of the message did not change as a consequence of serum induction. Altogether, our ®ndings suggest that the 5'-¯anking region of the human HMGIC gene contains constitutive promoter activity.
Discussion
In the present study, we have screened HMGIC mRNA expression in a large variety of cell lines. From its results, it is evident that HMGIC can not simply be considered a housekeeping gene that is abundantly expressed as is stated in many publications. Here, we show that HMGIC is not abundantly expressed in all cell lines tested. We also show that at least in a few of the cell lines tested, HMGIC expression is exquisitely regulated.
When exposed to appropriate dierentiation stimuli, 3T3-L1 preadipocytes lose their ®broblastic features, undergo one or two cycles of mitosis, round up and acquire the morphological and biochemical phenotype of adipocytes. Dierentiation of a cell is determined by the integration of stimulatory and inhibitory signals and occurs when forces that repress it are overcome by forces that stimulate it. In 3T3-L1 preadipocytes that were made quiescent by density arrest, the abundance of HMGIC mRNA reached a maximum 6 ± 9 h after serum addition (midpoint of G1) and was signi®cantly decreased 15 h after serum addition, that is, prior to the onset of S phase and DNA synthesis in these cells. The kinetics of HMGIC induction in 3T3-L1 preadipocytes is similar to that of cyclin D in 3T3 ®broblasts and is consistent with a mid-G1 regulation of HMGIC gene regulation. The timing of HMGIC expression in this dierentiation process suggests that HMGIC has a role in the proliferation step preceding and required for the later phases of adipocyte dierentiation.
It is also clear from our results that growth factors present in fetal calf serum were responsible for the strong induction of HMGIC mRNA levels in this growth and dierentiation model. Insulin or IGF-I were not able to induce HMGIC mRNA levels. PDGF-BB and FGF-1, on the other hand, were able to strongly induce the HMGIC gene. Inhibition of the PDGF receptor tyrosine kinase resulted in an almost complete inhibition of HMGIC mRNA induction by serum. This indicates that although FGF-1 is a strong inducer of HMGIC, a more critical serum component responsible for the induction of HMGIC must be PDGF. Of course, caution is to be taken in the interpretation of data obtained by using inhibitors. Therefore, future experiments will include Western analysis to de®nitely prove the activation of the signal transduction pathways suggested in our study.
The serum induction of HMGIC had a transient nature, peaking 6 ± 9 h after serum addition. However, induction of HMGIC by a single growth factor resulted in a more sustained expression, suggesting that the down regulation of HMGIC 9 h after serum addition was a regulated event resulting from active termination of the response. One likely mechanism to achieve this would be the recruitment of a repressor to shut o the gene. However, a recent study shows that the interferon-b (IFNb) enhanceosome already contains all the necessary information to not only activate transcription but also to terminate it (Munshi et al., 1998) . It is intriguing, that in the case of the IFNb promoter, HMGI has been shown to be involved in both the assembly of the enhanceosome (leading to transcriptional activation) but also in its destabilization after HMGI has been acetylated by CBP resulting in a Figure 9 RT ± PCR analysis of HMGIC mRNA and hnRNA. Quiescent 3T3-L1 preadipocytes were induced by serum. Total RNA was isolated after 0, 3, 6, 9, 14 and 24 h and subjected to RT ± PCR using primers speci®c for HMGIC mRNA (left) or HMGIC hnRNA (right). In RT minus control experiments no products were detected post-induction turno of the promoter (Munshi et al., 1998) .
Mouse embryo ®broblasts require more than one growth factor for optimal growth, usually IGF-I and PDGF. Neither of these growth factors by its own is able to stimulate growth optimally (Baserga et al., 1997) . An explanation for this could be that both the PDGF and IGF-I receptors activate separate and independent signal transduction pathways both of which are necessary but not sucient for mitogenesis. PDGF falls under the category of so-called commitment factors that are responsible for the transition from the quiescent (G0) to a growth competent state (G1), while IGF-I is considered a so-called progression factor that makes it possible for the cell to transverse to later stages of the cell cycle. This generally accepted view is however obscured by the observation that cells overexpressing a single growth factor receptor acquire the ability to grow in serum free medium supplemented with the corresponding growth factor alone. This would mean that all that is needed is a sucient high number of growth factor receptors per cell (regardless of the receptor type) and the corresponding growth factor. To exclude that low IGF-I receptor levels were responsible for the failure of IGF-I to induce HMGIC expression, we made a derivative cell line of 3T3-L1 highly overexpressing the human IGF-I receptor. When these cells were stimulated by IGF-I, HMGIC was induced to levels comparable to those obtained by EGF but these levels were still clearly much lower than those obtained by FGF-1 or PDGF-BB (unpublished observations). We conclude that although IGF-1 and insulin are very important for growth and differentiation of 3T3-L1 cells, they do not result in HMGIC induction in these cells.
Okadaic acid blocked the initial transient HMGIC mRNA induction, but after 14 h it led to a signi®cant increase in HMGIC mRNA levels at a time-point where HMGIC mRNA levels are normally downregulated. Even in serum free conditions, okadaic acid treatment resulted in high levels of HMGIC mRNA. This suggests that the inhibition of phosphatases overcomes the inhibitory forces that repress the HMGIC gene in quiescent cells. Two possible mechanisms can be responsible for this eect. Firstly, okadaic acid treatment can result in the activation of the immediate early-genes responsible for the delayedearly induction HMGIC. There are several observations that support this mechanism. Recently, it has been shown that okadaic acid was able to induce the expression of the transcription factor Egr-1 and by using a GAL4-Egr-1 fusion protein, it has been demonstrated that okadaic acid positively regulates Egr-1 transcriptional activity in vivo (Hyun et al., 1994) . Furthermore, okadaic acid treatment has also been shown to result in the induction of AP1. The fos family members: c-fos, fosB, and fra-1, but also the jun family members, c-jun, junB, and junD were demonstrated to be induced (Park et al., 1992) . Secondly, okadaic acid could result in the inactivation of a repressor of the HMGIC gene. This mechanism is consistent with the constitutive activity of the 5'-anking promoter region of HMGIC, suggesting that it is regulated by a repressor.
It should be noted that in transient transfection experiments the chromatin structure of the HMGIC promoter is not comparable with that of the endogenous HMGIC gene. However, HMGIC is frequently rearranged and overexpressed by chromosomal translocations in benign mesenchymal tumors. Many chromosomes have been found as translocation partners in the tumors studied (Schoenmakers et al., 1995) . One explanation for the multiple translocation partners involved, is that all that is required for the ectopic overexpression of HMGIC is the removal of the repressor element from its normal site or the juxtaposition of a strong enhancer releasing the inhibitory eect of the repressor and thus aecting HMGIC expression in adult dierentiated cells. Although these alternative mechanisms are not mutually exclusive, the results of the okadaic acid treatment indicate that protein phosphorylations and phosphatases play an important role in the transcriptional regulation of the HMGIC gene. In conclusion, our studies indicate that the expression of HMGIC is rather complex and further analysis is required to gain more insight in the molecular mechanisms underlying the regulation of HMGIC expression during growth and development.
Materials and methods
Primers
The following primers were used in this study: TA95-01: 5'-TCTTCTCCCTTCAAAAGATCCAACTG (speci®c for mouse and human exon 5); TA95-03: 5'-GCGCCCCCTAG-TCCTCTTCGGCAGA (speci®c for human exon 5); TA95-04: 5'-AGGCAGGATGAGCGCACGCGGTGA (speci®c for mouse and human exon 1); TA95-10: 5'-CGCGTCCTCTCT-TCTGAGG (speci®c for human exon 1); TA95-10M: 5'-CGCGTCCTCGCTTCTGTGGCAC (speci®c for mouse exon 1); TA95-13: 5'-GCGCCCCCTAATCCTCCTCTG-CGGA (speci®c for mouse exon 5); VW-1C: 5'-ACGGGG-TGGGCTGGTGC (speci®c for human intron 1); VW-1CM: 5'-GGCTGAGTGGCCCCTCC (speci®c for mouse intron 1); VWintron1: 5'-ACCGCGCCCTCGTACTGACTTG (speci®c for human intron 1); VWintron1M: 5'-TCCGCGTCGGCG-TACTGACTTG (speci®c for mouse intron 1).
RLM ± PCR primers: RNA linker: 5'-CGACCACUA-GUAGGGCAUAGGCUGACCCUCGCUGAAA; RLM-anchor: 5'-GGGCATAGGCTGACCCTCGCTGAAA.
Cell culture and transfection
All cell lines were obtained from the American Type Culture Collection (ATCC). Murine 3T3-L1 preadipocytes were grown in DMEM/F12 supplemented with 10% fetal calf serum (FCS) (Gibco ± BRL) containing TES and HEPES (Calbiochem). Preadipocytes were plated and grown 3 ± 4 days postcon¯uence in order for them to become quiescent (Student et al., 1980) . For the eect of drugs (see below) on the induction of HMGIC by serum, appropriate concentration of drugs were added for 1 h prior to serum induction (preincubation). Subsequently, the preincubation medium was replaced by fresh DMEM/F12 supplemented with 10% FCS and the appropriate concentration of the drug. Differentiation to adipocytes was performed basically by an established protocol (Student et al., 1980) and veri®ed by microscopy. Preadipocytes were plated and grown to 2 days postconuence. Dierentiation was then induced by changing the medium to DMEM/F12 supplemented with 10% FCS, 0.5 mM 3-isobutyl-1-methyl-xanthine (IBMX), 1 mM dexamethasone (DEX) and 10 mg/ml insulin (INS). After 48 h, the dierentiation medium was replaced by maintenance medium consisting of DMEM/F12 supplemented with 10% FCS and 10 mg/ml insulin. The maintenance medium was changed every other day for 7 days. For the analysis of HMGIC promoter activity, cells were seeded in 6-well plates and transfected with the various HMGIC promoter-luciferase reporter constructs ((1 mg DNA/ well) in pGL2-Basic vector (Promega)) using cationic liposomes and assayed for luciferase activity as previously described (Jansen et al., 1997) . In the p21Ras-mediated transactivation experiments, cells were shifted to serum-free medium 24 h prior to transfection and co-transfected with a DNA construct (100 ng/well) directing expression of constitutively active p21Ras (Leu61; Medema et al., 1991) . A Fos promoter-luciferase construct (7711/+45; Schonthal et al., 1988) was included as positive control for the p21Ras-mediated transactivation.
RNA extraction and Northern blot analysis
Total RNA was isolated from cells by extraction with guanidine isothiocyanate and centrifugation through 5.7 M CsCl 2 (Ausubel et al., 1995) or using Trizol reagent (Gibco ± BRL) using the protocol supplied by the manufacturer. RNA was glyoxylated, size fractionated through a 1% agarose gel, and transferred to Hybond-N using standard procedures (Ausubel et al., 1995) . The complete coding region of HMGIC or HMGI were used as hybridization probe. RNA on ®lters was stained with methylene blue in order to check for equal loading in each lane.
RT ± PCR on HMGIC mRNA
Total RNA was isolated as described above. Five mg of RNA was reversed transcribed using SuperScript II (Life Technologies) using the conditions described by the manufacturer. For detecting HMGIC mRNA transcripts, primer TA95-1 (exon 5) was used as reverse transcription primer. Following an incubation for 1 h at 468C, the reaction mixture was treated with RNase for 15 min at 378C and diluted to 100 ml with H 2 O. Ampli®cation of 2 ml of cDNA was performed by PCR in a ®nal volume of 100 ml containing 2.5 U Taq DNA Polymerase (Perkin Elmer), 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 0.01% gelatin and 0.2 mM dNTP's and 20 pmol of each primer. As forward primer TA95-4 (exon 1) and reverse primer TA95-13 (exon 5) were used. For detecting HMGIC hnRNA transcripts, primer VW-ICM (intron 1) was used as reverse transcription primer and TA95-4 and VWintron1M (intron 1) as forward and reverse primer, respectively. In addition, a second round of seminested PCR was performed using forward primer TA95-4 and reverse primer 95-10M. A Pharmacia LKB Gene ATAQ Controller was used, cycling at 958C for 1 min (denaturation), at 668C for 1 min (annealing) and at 728C for 1 min (extension) for between 20 and 30 cycles with a ®nal 5 min extension at 728C.
RLM ± RACE
The RLM ± RACE was performed as described (Schaefer, 1995) . The RNA sample is ®rst treated with alkaline phosphatase to remove the 5'-phosphates from any degraded RNAs. The mRNAs are subsequently decapped by treatment with tobacco acid pyrophosphatase (TAP) which hydrolyzes the phosphoric acid anhydride bonds in the triphosphate bridge of the mRNA cap. The TAP enzyme leaves a 5'-phosphate on decapped mRNAs and only these RNAs are substrates for T4 RNA ligase which is used to ligate an RNA linker of de®ned sequence to the exposed 5'-phosphates. The mRNA can now be reverse transcribed and only RNAs extending to the cap site are ampli®ed using a DNA primer (RLM-anchor) corresponding to the RNA linker, and two (nested) gene-speci®c primers.
